Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 4/20 | 0.57 |
| ▸ | ECE1 | P42892 | 3/20 | 0.55 |
| ▸ | NPY1R | P25929 | 3/20 | 0.54 |
| ▸ | NPY2R | P49146 | 3/20 | 0.54 |
| ▸ | NPY4R | P50391 | 3/20 | 0.54 |
| ▸ | CTSC | P53634 | 1/20 | 0.49 |
| ▸ | ANPEP | P15144 | 2/20 | 0.48 |
| ▸ | IL1RN | P18510 | 2/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.48 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.48 |
| ▸ | GHSR | Q92847 | 2/20 | 0.48 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 2/20 | 0.48 |
| ▸ | MMP8 | P22894 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14685608 | 0.91 | KISS1R (0.65) | KISS1RECE1 | |
| SCHEMBL29657322 | 0.91 | KISS1R (0.65) | KISS1RECE1 | |
| SCHEMBL29794196 | 0.91 | ECE1 (0.56) | KISS1RECE1NPY1RNPY2RNPY4R | |
| SCHEMBL29540094 | 0.91 | ECE1 (0.56) | KISS1RECE1NPY1RNPY2RNPY4R | |
| SCHEMBL29794114 | 0.91 | ECE1 (0.56) | KISS1RECE1NPY1RNPY2RNPY4R | |
| SCHEMBL31718765 | 0.89 | KISS1R (0.67) | KISS1RECE1 | |
| SCHEMBL29872870 | 0.88 | KISS1R (0.58) | KISS1RECE1GHSR | |
| SCHEMBL31193767 | 0.87 | NPY4R (0.60) | KISS1RECE1NPY1RNPY2RNPY4R | |
| SCHEMBL29872703 | 0.87 | KISS1R (0.64) | KISS1RECE1GHSR | |
| SCHEMBL30464865 | 0.86 | NPY4R (0.61) | KISS1RECE1NPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3650464-B1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | SHANGPHARMA INNOVATION INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-11981753-B2 | Peptide compound and application thereof, and composition containing peptide compound | SHANGPHARMA INNOVATION INC. (US) | 2024-05-14 | — | — | US | disclosed |
| US-11807660-B2 | Peptide compound and application thereof, and composition containing peptide compound | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2022-08-30 | — | — | US | disclosed |
| US-20220242908-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-08-04 | — | — | US | disclosed |
| US-20220213142-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981753-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, NPY1R, GLP1R | KISS1R 1/4885ECE1 861/4885NPY1R 2/4885 |
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, VIP, NPY1R | KISS1R 1/4885ECE1 728/4885NPY1R 3/4885 |
| US-20220213142-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, VIP, SSTR3 | KISS1R 1/4885ECE1 996/4885NPY1R 5/4885 |
| US-11807660-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, VIP, SSTR3 | KISS1R 1/4885ECE1 996/4885NPY1R 5/4885 |
| US-20220242908-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, NPY1R, GLP1R | KISS1R 1/4885ECE1 861/4885NPY1R 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.